Adam Mendizabal, PhD
Senior Vice President, Global Head of Cell and Gene Therapy
Cell and Gene Therapy
More than 45 years of experience
With a foundation built on decades of research and collaboration with leading investigators, our Cell and Gene Therapy team brings more than 45 years of invaluable expertise in conducting clinical trials to our customers.
Our innovations are unlocking real research potential to test and create life-changing treatments for patients suffering from a wide range of conditions and diseases.
Why Emmes?
Proven Expertise
Our 125+ clinical studies are focused on advancing cell or gene therapies in therapeutic areas including hematology/oncology, ophthalmology, cardiology, and pulmonology.
71 total submissions to regulatory agencies since 2019, including 15 IND/CTA submissions.
Over 100 scientific manuscripts co-authored by Emmes staff that include cell and gene therapy research results and progress.
The Blood and Marrow Transplant Clinical Trials Network (BMT CTN)
Complex Clinical Trials
The BMT CTN is one of our longest-running, most collaborative and complex research partnerships. The BMT CTN sets out to evaluate promising therapeutic approaches in multi-institutional clinical trials, aiming to improve the outcomes of blood and marrow transplantation and other cellular therapies for patients facing life-threatening blood disorders. The BMT CTN leverages processes and data from the Center for International Blood and Marrow Transplant Research (CIBMTR) that allows the BMT CTN to design and conduct these complex studies effectively.
It's funded by the National Heart, Lung, and Blood Institute (NHLBI) and the National Cancer Institute, in collaboration with biopharma companies. Other partners are the National Marrow Donor Program/Be the Match (NMDP) and the Medical College of Wisconsin (MCW).
Established in 2001, our partnership with NMDP MCW is the foundation of a program led by experts in the field of hematopoietic cell transplantation and cellular therapy.
In sharing responsibility, Emmes manages study operations, NMDP looks after patient advocacy and contracting, and MCW takes care of scientific leadership.
Cell and Gene Therapy Leaders
Denise King
Vice President, Cell and Gene Therapy Operations
Emmes Solutions and Services
Clinical trial operations
Study leadership
Statistical services
Pharmacovigilance
Regulatory, training and educational support
Electronic data capture of CRFs and patient reported outcomes
Patient diaries and data from phone apps and wearables
Digital technologies for site and patient-level data
Let's Connect
Schedule a Meeting
Let's discuss how our cell and gene therapy expertise can support your next study.
- Speak with a cell and gene therapy expert
- Tailored solutions for your study needs
- Quick and easy scheduling
Resources
Explore Helpful Resources
Access documents and insights to learn more about our capabilities.